Clinical Trials
Title: A Randomized, Double-Blind, Parallel-Group, Multicenter Study to Evaluate the Retention Rate, Efficacy, Safety, and Tolerability of Carisbamate, Topiramate, and Levetiracetam as Adjunctive in Subjects with Partial Onset Seizures
Department: Neurology. Condition: Epilepsy. Principal Investigator: Mercedes P. Jacobson, MD.
This research study has been reviewed and approved by the Temple University Institutional Review Board and is assigned IRB Protocol #12076.
Title: Lamotrigine Extended-Release in Elderly Patients with Epilepsy
Department: Neurology. Condition: Epilepsy. Principal Investigator: Mercedes P. Jacobson, MD.
This research study has been reviewed and approved by the Temple University Institutional Review Board and is assigned IRB Protocol #11191.
Title: A Randomized, Multicenter, Placebo-Controlled and Active Reference (Glatiramer Acetate) Comparison Study to Evaluate the Efficacy and Safety of BG00012 in Subjects with Relapsing-Remitting Multiple Sclerosis
Department: Neurology. Condition: Relapse-Remitting Multiple Sclerosis. Principal Investigator: S. Ausim Azizi, MD, PhD.
This research study has been reviewed and approved by the Temple University Institutional Review Board and is assigned IRB Protocol #11190.
Title: A Double-Blind, Randomized, Multicenter Efficacy and Safety Study of Pregabalin (Lyrica) as Monotherapy in Patients with Partial Seizures
Department: Neurology. Condition: Epilepsy. Principal Investigator: Mercedes P. Jacobson, MD.
This research study has been reviewed and approved by the Temple University Institutional Review Board and is assigned IRB Protocol #12374.
Title: A Multi-Center, Double-Blind, Historical Control, Randomized Conversion to Monotherapy Study With Keppra XR for Treatment of Partial Onset Seizures
Department: Neurology. Condition: Epilepsy. Principal Investigator: Mercedes P. Jacobson, MD.
This research study has been reviewed and approved by the Temple University Institutional Review Board and is assigned IRB Protocol #11227. Study Closed to Enrollment.